Jefferies Financial Group
AGIO icon

Jefferies Financial Group’s Agios Pharmaceuticals AGIO Stock Holding History

Jefferies Financial Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.02M Buy
+30,685
New +$1.07M 0.01% 766
2025
Q1 		– Sell
-1,500,000
Closed -$49.3M – 1571
2024
Q4 		$49.3M Buy
+1,500,000
New +$70.5M 0.3% 61

Other funds holding AGIO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Jefferies Financial Group's AGIO Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2026: 30,685 shares worth $1.02M. The stake represents 0.01% of the portfolio and ranks #766 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in AGIO as recently as Q4 2024.

Jefferies Financial Group first reported a position in AGIO in Q4 2024 and has held it in 2 quarters since. The position peaked at $49.3M in Q4 2024. 85 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Jefferies Financial Group held 30,685 shares of Agios Pharmaceuticals worth $1.02M as of Q3 2026.
  • Agios Pharmaceuticals was a new Jefferies Financial Group position in Q3 2026.
  • Agios Pharmaceuticals made up 0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #766 holding.
  • Jefferies Financial Group first reported a position in Agios Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
  • Jefferies Financial Group's Agios Pharmaceuticals position peaked at $49.3M in Q4 2024.
  • 85 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.